camptothecin has been researched along with Uremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukubo, T; Hojyo, A; Izumi, S; Kambara, K; Katsube, Y; Koide, H; Minegaki, T; Nishiguchi, K; Ochiai, M; Ogawa, K; Shima, D; Torii, N; Tsujimoto, M; Yamakawa, T | 1 |
| Allen, LM; Creaven, PJ; Muggia, FM | 1 |
2 other study(ies) available for camptothecin and Uremia
| Article | Year |
|---|---|
Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
Topics: Algorithms; Antineoplastic Agents, Phytogenic; Camptothecin; Dose-Response Relationship, Drug; Half-Life; HEK293 Cells; Humans; Irinotecan; Kidney Failure, Chronic; Liver; Liver-Specific Organic Anion Transporter 1; Renal Dialysis; Serum Albumin; Toxins, Biological; Uremia | 2017 |
Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity.
Topics: Camptothecin; Chromatography, Gel; Chromatography, Thin Layer; Filtration; Humans; Neoplasms; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Time Factors; Uremia | 1972 |